Diagnosis and management of bacterial meningitis in the paediatric population: a review

Catherine L Tacon1, Oliver Flower

  • 1Sydney Children's Hospital, Randwick, NSW, Australia.

Insights

Paediatric bacterial meningitis remains a serious neurological emergency. Advances in vaccines and diagnostics aid management, but prompt diagnosis and treatment are crucial for reducing child morbidity and mortality.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Pediatrics

Background:

  • Paediatric bacterial meningitis is a critical neurological emergency with substantial morbidity and mortality.
  • Vaccine development has altered disease epidemiology, yet it remains a condition demanding high clinical suspicion.
  • Early diagnosis and management in emergency departments are vital for improving outcomes.

Purpose of the Study:

  • To outline the evolving epidemiology of paediatric bacterial meningitis.
  • To review current diagnostic techniques and emerging laboratory/clinical tools.
  • To discuss controversies and recent advances in managing this condition in children.

Main Methods:

  • Literature review of epidemiological data, diagnostic advancements, and therapeutic strategies.
  • Analysis of current clinical guidelines and research on paediatric bacterial meningitis.
  • Synthesis of information on diagnostic controversies and novel management approaches.

Main Results:

  • Significant changes in bacterial meningitis epidemiology due to vaccination programs.
  • Improved diagnostic capabilities through new laboratory and clinical tools.
  • Ongoing debates and advancements in treatment protocols for paediatric cases.

Conclusions:

  • Despite progress, paediatric bacterial meningitis necessitates vigilance, rapid diagnosis, and timely intervention.
  • Understanding epidemiological shifts and diagnostic advancements is key for effective clinical practice.
  • Continued research into management strategies is essential to further reduce the impact of this disease.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...